2014
Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens
Lipsitch M, Galvani AP. Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens. PLOS Medicine 2014, 11: e1001646. PMID: 24844931, PMCID: PMC4028196, DOI: 10.1371/journal.pmed.1001646.Peer-Reviewed Original Research
2009
Optimizing Influenza Vaccine Distribution
Medlock J, Galvani AP. Optimizing Influenza Vaccine Distribution. Science 2009, 325: 1705-1708. PMID: 19696313, DOI: 10.1126/science.1175570.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedCenters for Disease Control and Prevention, U.S.ChildChild, PreschoolDisease OutbreaksHealth PolicyHumansImmunization ProgramsInfantInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanMiddle AgedModels, StatisticalUnited StatesVaccinationYoung AdultConceptsOutcome measuresNovel swine-origin influenzaOptimal vaccine allocationInfluenza vaccine distributionContingent valuationSwine-origin influenzaYears of lifePublic health policyOptimal allocationEconomic costsInfluenza vaccineSeasonal influenzaInfluenza pandemicU.S. CentersVaccine allocationDisease controlMortality dataVaccine distributionHealth policyOptimal vaccinationPolicy optimizationTransmission dynamicsInfluenzaAllocationNew recommendations
2003
Ecological and immunological determinants of influenza evolution
Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003, 422: 428-433. PMID: 12660783, DOI: 10.1038/nature01509.Peer-Reviewed Original ResearchConceptsNew avian influenzaHost immune systemStrain-transcending immunityImmunological factorsInfluenza ANew vaccinesAnnual epidemicsAntigenic shiftImmune systemAntigenic changesEpidemic formHigh transmissibilityImmunological determinantsInfluenzaAvian influenzaGlobal pandemicInfluenza evolutionViral evolutionViral diversityEpidemiological dynamicsMorbidityVaccineMortalitySubtypesImmunity